NY-ESO-1 peptide vaccine
Term · Oncology and biomedicine · MLC-T-ONC-015561
A cancer vaccine consisting of an immunogenic peptide derived from the cancer-testis antigen (NY-ESO-1), an antigen found in normal testis and various tumors. Vaccination with NY-ESO-1 peptide vaccine may stimulate the host immune system to mount a humoral and cytotoxic T lymphocyte (CTL) response to cells expressing NY-ESO-1 antigen, resulting in tumor cell lysis.
| Identifier | MLC-T-ONC-015561 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | ESO-1 Peptide Vaccine |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-015561",
"term": "NY-ESO-1 peptide vaccine",
"field": "Oncology and biomedicine",
"definition": "A cancer vaccine consisting of an immunogenic peptide derived from the cancer-testis antigen (NY-ESO-1), an antigen found in normal testis and various tumors. Vaccination with NY-ESO-1 peptide vaccine may stimulate the host immune system to mount a humoral and cytotoxic T lymphocyte (CTL) response to cells expressing NY-ESO-1 antigen, resulting in tumor cell lysis.",
"synonyms": [
"ESO-1 Peptide Vaccine"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/ny-eso-1-peptide-vaccine/"
}
Record 12,037 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.